- Takeaway:
The Supreme Court heads into the 2014-15 term with only one patent case on its schedule, compared to six last term.
The U.S. Supreme Court has granted review in only one patent case so far this term, compared with the six it decided last term.
The court passed on eight additional patent cases from its Sept. 29 conference as it opened its 2014-2015 term Oct. 6.
The lone patent case on the docket so far, Teva Pharm. USA, Inc. v. Sandoz, Inc., U.S., 13-854, argument scheduled183 PTD, 9/22/14, 88 PTCJ 1332, 9/26/14, 183 DER A-32, 9/22/14, challenges ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.